Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02149108
Title Nintedanib (BIBF 1120) vs Placebo in Refractory Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult
Covered Countries USA | TUR | SWE | POL | NLD | ITA | ISR | GBR | FRA | ESP | DNK | DEU | CZE | CAN | BEL | AUT | AUS | ARG

Facility Status City State Zip Country Details
1199.52.0108 Boehringer Ingelheim Investigational Site Los Angeles California United States Details
1199.52.0105 Boehringer Ingelheim Investigational Site New Haven Connecticut United States Details
1199.52.0101 Boehringer Ingelheim Investigational Site Plainville Connecticut United States Details
1199.52.0121 Boehringer Ingelheim Investigational Site Arlington Heights Illinois United States Details
1199.52.0123 Boehringer Ingelheim Investigational Site Sioux City Iowa United States Details
1199.52.0104 Boehringer Ingelheim Investigational Site Topeka Kansas United States Details
1199.52.0114 Boehringer Ingelheim Investigational Site New Orleans Louisiana United States Details
1199.52.0113 Boehringer Ingelheim Investigational Site Detroit Michigan United States Details
1199.52.0125 Boehringer Ingelheim Investigational Site Omaha Nebraska United States Details
1199.52.0119 Boehringer Ingelheim Investigational Site Johnson City New York United States Details
1199.52.0115 Boehringer Ingelheim Investigational Site Canton Ohio United States Details
1199.52.0106 Boehringer Ingelheim Investigational Site Sylvania Ohio United States Details
1199.52.0102 Boehringer Ingelheim Investigational Site Nashville Tennessee United States Details
1199.52.0120 Boehringer Ingelheim Investigational Site Fort Worth Texas United States Details
1199.52.5404 Boehringer Ingelheim Investigational Site Cdad. de Córdoba Argentina Details
1199.52.5405 Boehringer Ingelheim Investigational Site Cdad. de Córdoba Argentina Details
1199.52.5401 Boehringer Ingelheim Investigational Site Ciudad Autónoma de Bs As Argentina Details
1199.52.5403 Boehringer Ingelheim Investigational Site Ciudad Autónoma de Bs As Argentina Details
1199.52.5406 Boehringer Ingelheim Investigational Site Ciudad Autónoma de Bs As Argentina Details
1199.52.6102 Boehringer Ingelheim Investigational Site Concord New South Wales Australia Details
1199.52.6103 Boehringer Ingelheim Investigational Site St Leonards New South Wales Australia Details
1199.52.6101 Boehringer Ingelheim Investigational Site Wollongong New South Wales Australia Details
1199.52.6104 Boehringer Ingelheim Investigational Site Heidelberg Victoria Australia Details
1199.52.6105 Boehringer Ingelheim Investigational Site Nedlands Western Australia Australia Details
1199.52.6106 Boehringer Ingelheim Investigational Site Perth Western Australia Australia Details
1199.52.4302 Boehringer Ingelheim Investigational Site Linz Austria Details
1199.52.4303 Boehringer Ingelheim Investigational Site Wien Austria Details
1199.52.4304 Boehringer Ingelheim Investigational Site Wien Austria Details
1199.52.3208 Boehringer Ingelheim Investigational Site Aalst Belgium Details
1199.52.3205 Boehringer Ingelheim Investigational Site Bonheiden Belgium Details
1199.52.3202 Boehringer Ingelheim Investigational Site Bruxelles Belgium Details
1199.52.3207 Boehringer Ingelheim Investigational Site Charleroi Belgium Details
1199.52.3204 Boehringer Ingelheim Investigational Site Edegem Belgium Details
1199.52.3203 Boehringer Ingelheim Investigational Site Haine-Saint-Paul Belgium Details
1199.52.3201 Boehringer Ingelheim Investigational Site Leuven Belgium Details
1199.52.3206 Boehringer Ingelheim Investigational Site Liège Belgium Details
1199.52.3521 Boehringer Ingelheim Investigational Site Luxembourg Belgium Details
1199.52.1003 Boehringer Ingelheim Investigational Site Vancouver British Columbia Canada Details
1199.52.1004 Boehringer Ingelheim Investigational Site Edmonton Ontario Canada Details
1199.52.1001 Boehringer Ingelheim Investigational Site Toronto Ontario Canada Details
1199.52.1002 Boehringer Ingelheim Investigational Site Montreal Quebec Canada Details
1199.52.4202 Boehringer Ingelheim Investigational Site Brno Czechia Details
1199.52.4204 Boehringer Ingelheim Investigational Site Hradec Kralove Czechia Details
1199.52.4201 Boehringer Ingelheim Investigational Site Prague Czechia Details
1199.52.4502 Boehringer Ingelheim Investigational Site Herning Denmark Details
1199.52.4501 Boehringer Ingelheim Investigational Site København Ø Denmark Details
1199.52.4503 Boehringer Ingelheim Investigational Site Næstved Denmark Details
1199.52.4504 Boehringer Ingelheim Investigational Site Odense C Denmark Details
1199.52.3304 Boehringer Ingelheim Investigational Site Lille cedex France Details
1199.52.3307 Boehringer Ingelheim Investigational Site Lyon cedex 8 France Details
1199.52.3305 Boehringer Ingelheim Investigational Site Paris cedex 15 France Details
1199.52.3301 Boehringer Ingelheim Investigational Site Reims Cedex France Details
1199.52.4906 Boehringer Ingelheim Investigational Site Dresden Germany Details
1199.52.4905 Boehringer Ingelheim Investigational Site Essen Germany Details
1199.52.4904 Boehringer Ingelheim Investigational Site Freiburg Germany Details
1199.52.4903 Boehringer Ingelheim Investigational Site Mannheim Germany Details
1199.52.4901 Boehringer Ingelheim Investigational Site Ulm Germany Details
1199.52.8501 Boehringer Ingelheim Investigational Site Hong Kong Hong Kong Details
1199.52.8502 Boehringer Ingelheim Investigational Site Hong Kong Hong Kong Details
1199.52.8503 Boehringer Ingelheim Investigational Site Hong Kong Hong Kong Details
1199.52.8504 Boehringer Ingelheim Investigational Site Hong Kong Hong Kong Details
1199.52.9706 Boehringer Ingelheim Investigational Site Beer Sheva Israel Details
1199.52.9704 Boehringer Ingelheim Investigational Site Petach Tikva Israel Details
1199.52.9703 Boehringer Ingelheim Investigational Site Tel Aviv Israel Details
1199.52.3901 Boehringer Ingelheim Investigational Site Genova Italy Details
1199.52.3906 Boehringer Ingelheim Investigational Site Milano Italy Details
1199.52.3907 Boehringer Ingelheim Investigational Site Napoli Italy Details
1199.52.3905 Boehringer Ingelheim Investigational Site Padova Italy Details
1199.52.3903 Boehringer Ingelheim Investigational Site Pisa Italy Details
1199.52.3904 Boehringer Ingelheim Investigational Site San Giovanni Rotondo (FG) Italy Details
1199.52.8102 Boehringer Ingelheim Investigational Site Aichi, Nagoya Japan Details
1199.52.8105 Boehringer Ingelheim Investigational Site Chiba, Chiba Japan Details
1199.52.8101 Boehringer Ingelheim Investigational Site Chiba, Kashiwa Japan Details
1199.52.8107 Boehringer Ingelheim Investigational Site Ehime, Matsuyama Japan Details
1199.52.8106 Boehringer Ingelheim Investigational Site Fukuoka, Fukuoka Japan Details
1199.52.8108 Boehringer Ingelheim Investigational Site Hokkaido, Sapporo Japan Details
1199.52.8115 Boehringer Ingelheim Investigational Site Hyogo, Amagasaki Japan Details
1199.52.8112 Boehringer Ingelheim Investigational Site Hyogo, Kobe Japan Details
1199.52.8114 Boehringer Ingelheim Investigational Site Ibaraki, Tsukuba Japan Details
1199.52.8110 Boehringer Ingelheim Investigational Site Oita, Yufu Japan Details
1199.52.8116 Boehringer Ingelheim Investigational Site Osaka, Osaka Japan Details
1199.52.8103 Boehringer Ingelheim Investigational Site Osaka, Suita Japan Details
1199.52.8109 Boehringer Ingelheim Investigational Site Saitama, Kitaadachi-gun Japan Details
1199.52.8104 Boehringer Ingelheim Investigational Site Shizuoka, Sunto-gun Japan Details
1199.52.8113 Boehringer Ingelheim Investigational Site Tokyo , Shinagawa-ku Japan Details
1199.52.8111 Boehringer Ingelheim Investigational Site Tokyo, Koto-ku Japan Details
1199.52.8202 Boehringer Ingelheim Investigational Site Goyang Korea, Republic of Details
1199.52.8201 Boehringer Ingelheim Investigational Site Seoul Korea, Republic of Details
1199.52.8203 Boehringer Ingelheim Investigational Site Seoul Korea, Republic of Details
1199.52.8204 Boehringer Ingelheim Investigational Site Seoul Korea, Republic of Details
1199.52.5201 Boehringer Ingelheim Investigational Site Mexico Mexico Details
1199.52.3101 Boehringer Ingelheim Investigational Site Amsterdam Netherlands Details
1199.52.3103 Boehringer Ingelheim Investigational Site Amsterdam Netherlands Details
1199.52.3102 Boehringer Ingelheim Investigational Site Utrecht Netherlands Details
1199.52.4801 Boehringer Ingelheim Investigational Site Jelenia Gora Poland Details
1199.52.4803 Boehringer Ingelheim Investigational Site Poznan Poland Details
1199.52.4804 Boehringer Ingelheim Investigational Site Wroclaw Poland Details
1199.52.3504 Boehringer Ingelheim Investigational Site Almada Portugal Details
1199.52.3502 Boehringer Ingelheim Investigational Site Coimbra Portugal Details
1199.52.3505 Boehringer Ingelheim Investigational Site Loures Portugal Details
1199.52.3501 Boehringer Ingelheim Investigational Site Porto Portugal Details
1199.52.3506 Boehringer Ingelheim Investigational Site Porto Portugal Details
1199.52.0701 Boehringer Ingelheim Investigational Site Moscow Russian Federation Details
1199.52.0703 Boehringer Ingelheim Investigational Site Moscow Russian Federation Details
1199.52.0702 Boehringer Ingelheim Investigational Site St. Petersburg Russian Federation Details
1199.52.0707 Boehringer Ingelheim Investigational Site Tyumen Russian Federation Details
1199.52.3401 Boehringer Ingelheim Investigational Site Barcelona Spain Details
1199.52.3402 Boehringer Ingelheim Investigational Site L'Hospitalet de Llobregat Spain Details
1199.52.3406 Boehringer Ingelheim Investigational Site La Coruña Spain Details
1199.52.3403 Boehringer Ingelheim Investigational Site Madrid Spain Details
1199.52.3404 Boehringer Ingelheim Investigational Site Madrid Spain Details
1199.52.3405 Boehringer Ingelheim Investigational Site Santander Spain Details
1199.52.3407 Boehringer Ingelheim Investigational Site Sevilla Spain Details
1199.52.4601 Boehringer Ingelheim Investigational Site Stockholm Sweden Details
1199.52.4602 Boehringer Ingelheim Investigational Site Uppsala Sweden Details
1199.52.8805 Boehringer Ingelheim Investigational Site Kaohsiung Taiwan Details
1199.52.8801 Boehringer Ingelheim Investigational Site Taipei Taiwan Details
1199.52.8803 Boehringer Ingelheim Investigational Site Taipei Taiwan Details
1199.52.8802 Boehringer Ingelheim Investigational Site Taoyuan County Taiwan Details
1199.52.9005 Boehringer Ingelheim Investigational Site Adana Turkey Details
1199.52.9001 Boehringer Ingelheim Investigational Site Ankara Turkey Details
1199.52.9003 Boehringer Ingelheim Investigational Site Antalya Turkey Details
1199.52.9004 Boehringer Ingelheim Investigational Site Istanbul Turkey Details
1199.52.9002 Boehringer Ingelheim Investigational Site Izmir Turkey Details
1199.52.4401 Boehringer Ingelheim Investigational Site Aberdeen United Kingdom Details
1199.52.4403 Boehringer Ingelheim Investigational Site Manchester United Kingdom Details
1199.52.4402 Boehringer Ingelheim Investigational Site Middlesex United Kingdom Details
1199.52.4405 Boehringer Ingelheim Investigational Site Nottingham United Kingdom Details
1199.52.4404 Boehringer Ingelheim Investigational Site Southampton United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field